000			01968 a2200553 4500
005			20250514021810.0
264		0	_c20020329
008			200203s 0 0 eng d
022			_a0268-3369
024	7		_a10.1038/sj.bmt.1703216 _2doi
040			_aNLM _beng _cNLM
100	1		_aChakrabarti, S
245	0	0	_aPre-emptive oral ribavirin therapy of paramyxovirus infections after haematopoietic stem cell transplantation: a pilot study. _h[electronic resource]
260			_bBone marrow transplantation _cOct 2001
300			_a759-63 p. _bdigital
500			_aPublication Type: Journal Article
650	0	4	_aAdministration, Oral
650	0	4	_aAdult
650	0	4	_aAnemia _xchemically induced
650	0	4	_aAnemia, Aplastic _xtherapy
650	0	4	_aAntiviral Agents _xadministration & dosage
650	0	4	_aDrug Administration Schedule
650	0	4	_aFemale
650	0	4	_aGraft vs Host Disease _xcomplications
650	0	4	_aHematologic Neoplasms _xtherapy
650	0	4	_aHematopoietic Stem Cell Transplantation
650	0	4	_aHumans
650	0	4	_aImmunocompromised Host
650	0	4	_aMale
650	0	4	_aMiddle Aged
650	0	4	_aNausea _xchemically induced
650	0	4	_aParainfluenza Virus 3, Human _xdrug effects
650	0	4	_aPilot Projects
650	0	4	_aPneumonia, Viral _xdrug therapy
650	0	4	_aPopulation Surveillance
650	0	4	_aProspective Studies
650	0	4	_aRespiratory Syncytial Virus Infections _xdrug therapy
650	0	4	_aRespirovirus Infections _xdrug therapy
650	0	4	_aRibavirin _xadministration & dosage
650	0	4	_aTransplantation Conditioning _xadverse effects
650	0	4	_aTreatment Outcome
700	1		_aCollingham, K E
700	1		_aHolder, K
700	1		_aFegan, C D
700	1		_aOsman, H
700	1		_aMilligan, D W
773	0		_tBone marrow transplantation _gvol. 28 _gno. 8 _gp. 759-63
856	4	0	_uhttps://doi.org/10.1038/sj.bmt.1703216 _zAvailable from publisher's website
999			_c11693329 _d11693329